amass technologies Aps
Core data
Name | amass technologies Aps |
Address | Nordre Fasanvej 215, 2000, Frederiksberg |
Founded | Nov 22, 2022 |
Employees (CVR) | 6 |
Locations (P-units) | 1View locations |
Website | https://amass.tech/ |
| amass-technologies | |
Branch | Computerprogrammering (621000) |
Name | amass technologies Aps |
Address | Nordre Fasanvej 215, 2000, Frederiksberg |
Founded | Nov 22, 2022 |
Employees (CVR) | 6 |
Locations (P-units) | 1View locations |
Website | https://amass.tech/ |
| amass-technologies | |
Branch | Computerprogrammering (621000) |
Keep track of amass technologies Aps
Description
Amass is scientific intelligence infrastructure for life science, turning fragmented scientific knowledge into a shared, traceable intelligence layer. It provides evidence-based answers and workflows across literature, patents, clinical trials, regulatory sources, web data, and internal documents.
Amass retrieves, structures, synthesizes, and reasons over scientific evidence so researchers, investors, developers, and strategy teams can make traceable decisions. The platform is available through an app, API, and MCP, with specialized data layers for biomedical literature, scholarly literature, patents, regulatory documents, drugs, clinical trials, genes, and web sources.
Products & services
Amass app · API · MCP integration · Amass Core infrastructure · BiomedCore · ScholarCore · PatentCore · RegulatoryCore · DrugCore · TrialCore · GeneCore · WebCore · Enterprise deployments with SLA, single-tenant hosting, and onboarding support
Industries
Scientific intelligence infrastructure · Life science research technology · Evidence retrieval and knowledge workflows
Customer types
Life science teams · Researchers · Investors · Developers · Strategy teams · Research institutions · Leading life science companies
Financials
| Reporting period | 2025DKK | |||
|---|---|---|---|---|
| Gross profit | -315,972 | |||
| Operating profit | -2,045,791 | |||
| Profit before tax | -2,047,857 | |||
| Net income | -1,858,490 | |||
| Total assets | 8,730,345 | |||
| Equity | 5,657,862 | |||
2022–2025 Unlock financial history | ||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Alexander Junge | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • DIREKTØR |
| Bodil Sidén | Roles Board | TitlesBESTYRELSESMEDLEM |
| Henrik Jensen | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • ADM. DIR. |
| Tommy Ahlers | Roles Board | TitlesBESTYRELSESMEDLEM |
Auditor
No auditor data available
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership33.33–49.99 % | Voting rights33.33 % | FromJun 23, 2025 | |
| Ownership33.33–49.99 % | Voting rights33.33 % | FromJun 23, 2025 | |
Unknown Other Participant | Ownership10–14.99 % | Voting rights10 % | FromJun 23, 2025 |
| Ownership5–9.99 % | Voting rights5 % | FromJun 23, 2025 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| Alexander Junge | Ownership through | 33.33–49.99 % |
| Henrik Jensen | Ownership through | 33.33–49.99 % |
| 🇬🇧Giant Ventures Seed II LP | Ownership through Direct | 10–14.99 % |
| Danmarks Eksport- og Investeringsfond | Ownership through | 1.25–3.33 % |
| Tais Clausen | 0.45–1.5 % | |
| Nikolaj Hoffmann Deichmann | 0.4–1.5 % | |
| 🇸🇪Gullspång Re:Food II Invest AB | Ownership through | 0.25–1 % |
| Christian René Tang-Jespersen | 0.16–0.75 % | |
| Jacob Nelson Lee Ørnstrand | 0.12–0.5 % | |
| FATBOYS FUTURE ApS | Ownership through | 0.08–0.45 % |
| Morten Bjerg Hulthin Rasmussen | 0.02–0.13 % |